Global biopharmaceutical company Almirall has entered into a research collaboration with the Centre for Genomic Regulation (CRG), an international biomedical research institute of excellence....
The Brazilian Health Regulatory Agency, Agência Nacional de Vigilância Sanitária (Anvisa) has granted marketing authorization for Y-mAbs Therapeutics' DANYELZA (naxitamab-gqgk) 40mg/10mL injection. DANYELZA will...
The U.S. Food and Drug Administration (FDA) has approved Innoviva Specialty Therapeutics' XACDURO (sulbactam for injection; durlobactam for injection), co-packaged for intravenous use in...